Related Experiment Video
Updated: Dec 10, 2025

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
Aging-associated changes in CD47 arrangement and interaction with thrombospondin-1 on red blood cells visualized by
Feng Wang1,2, Yan-Hou Liu1,2, Ting Zhang1,2
1Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital, Institute of Immunology, Jilin University, Changchun, China.
Insights
Aging red blood cells (RBCs) show altered CD47 clustering and increased thrombospondin-1 (TSP-1) binding, impacting RBC clearance. TSP-1 binding strength depends on CD47 distribution, not quantity, revealing mechanisms for aged RBC removal.
Area of Science:
- Cell Biology
- Immunology
- Hematology
Background:
- CD47 and thrombospondin-1 (TSP-1) are implicated in clearing aged red blood cells (RBCs).
- Aging-associated changes in CD47, TSP-1, and SIRPα expression and interaction on RBCs remain unclear.
- Understanding these molecular dynamics is crucial for explaining aged RBC clearance.
Purpose of the Study:
- To investigate aging-associated changes in CD47 distribution and TSP-1 interaction on RBCs.
- To elucidate the role of CD47 clustering and TSP-1 binding in aged RBC clearance.
- To provide nanoscale insights into the molecular mechanisms of RBC aging and removal.
Main Methods:
- Utilized direct stochastic optical reconstruction microscopy (dSTORM) for high-resolution imaging of RBCs.
- Quantitatively analyzed CD47 nanocluster formation and TSP-1 binding on young and aged RBCs.
- Investigated CD47 cluster formation in thbs1-/- mice and after TSP-1 exposure.
Main Results:
- Young RBCs exhibit sparse CD47 nanoclusters with minimal TSP-1 binding.
- Aged RBCs show decreased CD47 quantity but larger, denser clusters with enhanced TSP-1 binding.
- TSP-1 exposure increased CD47 cluster size via lipid rafts; inhibition in thbs1-/- mice prolonged RBC lifespan.
Conclusions:
- CD47-TSP-1 binding strength is dictated by CD47 distribution patterns, not absolute amounts, on RBCs.
- TSP-1 plays a direct role in the phagocytosis of aged RBCs.
- This study offers nanoscale visualization of CD47 dynamics and TSP-1 interactions, clarifying aged RBC removal mechanisms.
Abstract:
CD47 serves as a ligand for signaling regulatory protein α (SIRPα) and as a receptor for thrombospondin-1 (TSP-1). Although CD47, TSP-1, and SIRPα are thought to be involved in the clearance of aged red blood cells (RBCs), aging-associated changes in the expression and interaction of these molecules on RBCs have been elusive. Using direct stochastic optical reconstruction microscopy (dSTORM)-based imaging and quantitative analysis, we can report that CD47 molecules on young RBCs reside as nanoclusters with little binding to TSP-1, suggesting a minimal role for TSP-1/CD47 signaling in normal RBCs. On aged RBCs, CD47 molecules decreased in number but formed bigger and denser clusters, with increased ability to bind TSP-1. Exposure of aged RBCs to TSP-1 resulted in a further increase in the size of CD47 clusters via a lipid raft-dependent mechanism. Furthermore, CD47 cluster formation was dramatically inhibited on thbs1-/- mouse RBCs and associated with a significantly prolonged RBC lifespan. These results indicate that the strength of CD47 binding to its ligand TSP-1 is predominantly determined by the distribution pattern and not the amount of CD47 molecules on RBCs, and offer direct evidence for the role of TSP-1 in phagocytosis of aged RBCs. This study provides clear nanoscale pictures of aging-associated changes in CD47 distribution and TSP-1/CD47 interaction on the cell surface, and insights into the molecular basis for how these molecules coordinate to remove aged RBCs.
More Related Videos
09:01Integrate Imaging Flow Cytometry and Transcriptomic Profiling to Evaluate Altered Endocytic CD1d Trafficking
Published on: October 29, 2018
08:44An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
Published on: August 21, 2020